VIP and infection: Following, we compared two treatment protocols: a single post-infection treatment (day 1) using optimal and suboptimal VIP and PACAP concentrations (relative to inhibition of HIV-1 replication) (Figure 1B) and a consecutive treatment with three doses of each neuropeptide (on day 1, 5, and 10) at both concentration levels (Figure 1C).